Jamilian et al. (63) conducted a randomized, double-blind, placebo-controlled trial whose findings indicated that prolonged administration of soy isoflavones for 12 weeks diminished serum insulin levels in individuals with PCOS, thereby enhancing their insulin sensitivity. The gene discussed is INS; the disease is polycystic ovary syndrome.